Trial Profile
Pilot Study to Evaluate the Tolerability of Velcade (Bortezomib) and Pravastatin for the Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Pravastatin
- Indications Leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 02 Apr 2021 Status changed from active, no longer recruiting to discontinued.
- 12 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Feb 2017 Planned End Date changed from 1 Aug 2019 to 1 Aug 2020.